|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kim MY, Cho JH and Cho JY: Ever-changing
endoscopic treatment for early gastric cancer:
yesterday-today-tomorrow. World J Gastroenterol. 20:13273–13283.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
De Vita F, Di Martino N, Fabozzi A, et al:
Clinical management of advanced gastric cancer: the role of new
molecular drugs. World J Gastroenterol. 20:14537–14558. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gomez-Orte E, Saenz-Narciso B, Moreno S
and Cabello J: Multiple functions of the noncanonical Wnt pathway.
Trends Genet. 29:545–553. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tanaka SS, Kojima Y, Yamaguchi YL,
Nishinakamura R and Tam PP: Impact of WNT signaling on tissue
lineage differentiation in the early mouse embryo. Dev Growth
Differ. 53:843–856. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
MacDonald BT, Tamai K and He X:
Wnt/beta-catenin signaling: components, mechanisms, and diseases.
Dev Cell. 17:9–26. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Takahashi-Yanaga F: Activator or
inhibitor? GSK-3 as a new drug target. Biochem Pharmacol.
86:191–199. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jamieson C, Sharma M and Henderson BR:
Targeting the beta-catenin nuclear transport pathway in cancer.
Semin Cancer Biol. 27:20–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Veeck J and Dahl E: Targeting the Wnt
pathway in cancer: the emerging role of Dickkopf-3. Biochim Biophys
Acta. 1825:18–28. 2012.
|
|
10
|
Katoh M and Katoh M: WNT signaling pathway
and stem cell signaling network. Clin Cancer Res. 13:4042–4045.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Qu Y, Dang S and Hou P: Gene methylation
in gastric cancer. Clin Chim Acta. 424:53–65. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hibi K, Sakata M, Yokomizi K, et al:
Methylation of the WNT5A gene is frequently detected in early
gastric carcinoma. Hepatogastroenterology. 59:2661–2663.
2012.PubMed/NCBI
|
|
13
|
Katoh M: WNT/PCP signaling pathway and
human cancer (review). Oncol Rep. 14:1583–1588. 2005.PubMed/NCBI
|
|
14
|
Cui J, Xi H, Cai A, Bian S, Wei B and Chen
L: Decreased expression of Sox7 correlates with the upregulation of
the Wnt/beta-catenin signaling pathway and the poor survival of
gastric cancer patients. Int J Mol Med. 34:197–204. 2014.PubMed/NCBI
|
|
15
|
Yu J, Tao Q, Cheng YY, et al: Promoter
methylation of the Wnt/beta-catenin signaling antagonist Dkk-3 is
associated with poor survival in gastric cancer. Cancer. 115:49–60.
2009. View Article : Google Scholar
|
|
16
|
Fujimoto T, Tomizawa M and Yokosuka O:
SiRNA of frizzled-9 suppresses proliferation and motility of
hepatoma cells. Int J Oncol. 35:861–866. 2009.PubMed/NCBI
|
|
17
|
Tomizawa M, Shinozaki F, Motoyoshi Y, et
al: Niclosamide suppresses Hepatoma cell proliferation via the Wnt
pathway. Onco Targets Ther. 6:1685–1693. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tomizawa M, Shinozaki F, Sugiyama T,
Yamamoto S, Sueishi M and Yoshida T: Frizzled-2: A potential novel
target for molecular pancreatic cancer therapy. Oncol Lett.
7:74–78. 2014.
|
|
19
|
Tomizawa M, Shinozaki F, Motoyoshi Y,
Sugiyama T, Yamamoto S and Sueishi M: Short hairpin RNA of
frizzled-2 suppresses the proliferation of hepatocellular carcinoma
cells. Oncol Lett. 8:1519–1522. 2014.PubMed/NCBI
|
|
20
|
Casimiro MC, Velasco-Velazquez M,
Aguirre-Alvarado C and Pestell RG: Overview of cyclins D1 function
in cancer and the CDK inhibitor landscape: past and present. Expert
Opin Investig Drugs. 23:295–304. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Vandooren J, Van den Steen PE and
Opdenakker G: Biochemistry and molecular biology of gelatinase B or
matrix metalloproteinase-9 (MMP-9): the next decade. Crit Rev
Biochem Mol Biol. 48:222–272. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sagara N, Toda G, Hirai M, Terada M and
Katoh M: Molecular cloning, differential expression, and
chromosomal localization of human frizzled-1, frizzled-2, and
frizzled-7. Biochem Biophys Res Commun. 252:117–122. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kirikoshi H, Koike J, Sagara N, et al:
Molecular cloning and genomic structure of human frizzled-3 at
chromosome 8p21. Biochem Biophys Res Commun. 271:8–14. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kirikoshi H, Sagara N, Koike J, et al:
Molecular cloning and characterization of human Frizzled-4 on
chromosome 11q14-q21. Biochem Biophys Res Commun. 264:955–961.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Saitoh T, Hirai M and Katoh M: Molecular
cloning and characterization of human Frizzled-5 gene on chromosome
2q33.3-q34 region. Int J Oncol. 19:105–110. 2001.PubMed/NCBI
|
|
26
|
Tokuhara M, Hirai M, Atomi Y, Terada M and
Katoh M: Molecular cloning of human Frizzled-6. Biochem Biophys Res
Commun. 243:622–627. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Saitoh T, Hirai M and Katoh M: Molecular
cloning and characterization of human Frizzled-8 gene on chromosome
10p11.2. Int J Oncol. 18:991–996. 2001.PubMed/NCBI
|
|
28
|
Wang YK, Samos CH, Peoples R, Perez-Jurado
LA, Nusse R and Francke U: A novel human homologue of the
Drosophila frizzled wnt receptor gene binds wingless protein and is
in the Williams syndrome deletion at 7q11.23. Hum Mol Genet.
6:465–472. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Koike J, Takagi A, Miwa T, Hirai M, Terada
M and Katoh M: Molecular cloning of Frizzled-10, a novel member of
the Frizzled gene family. Biochem Biophys Res Commun. 262:39–43.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lee MA, Park JH, Rhyu SY, Oh ST, Kang WK
and Kim HN: Wnt3a expression is associated with MMP-9 expression in
primary tumor and metastatic site in recurrent or stage IV
colorectal cancer. BMC Cancer. 14:1252014. View Article : Google Scholar : PubMed/NCBI
|
